UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| ||
( | (Zip Code) |
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered |
The |
Item 2.02. Results of Operations and Financial Condition.
Furnished as Exhibit 99 is a press release of NVE Corporation reporting results for the quarter and fiscal year ended March 31, 2024.
Item 8.01. Other Events.
NVE Corporation announced that its Board of Directors approved a quarterly cash dividend to shareholders of $1.00 per share of common stock, payable May 31, 2024, to shareholders of record as of May 13, 2024.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date May 1, 2024 | NVE CORPORATION
|
|
3
INDEX TO EXHIBITS
Exhibit #
| Description
|
99 | Press release of NVE Corporation reporting results for the quarter and fiscal year ended March 31, 2024, and announcing a quarterly dividend.
|
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
4
NVE Corporation Reports Fourth Quarter and Fiscal Year Results
and Announces Quarterly Dividend
EDEN PRAIRIE, Minn.—May 1, 2024—NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and fiscal year ended March 31, 2024.
Total revenue for the fourth quarter of fiscal 2024 decreased 45% to $7.08 million from $12.8 million for the prior-year quarter. The decrease was due to a 43% decrease in product sales and an 88% decrease in contract research and development revenue. Net income for the fourth quarter of fiscal 2024 decreased 54% to $3.81 million, or $0.79 per diluted share, compared to $8.23 million, or $1.70 per diluted share, for the prior-year quarter.
For fiscal 2024, total revenue decreased 22% to $29.8 million, compared to $38.3 million in the prior year. The decrease was due to a 21% decrease in product sales and a 45% decrease in contract research and development revenue. Net income for fiscal 2024 decreased 25% to $17.1 million, or $3.54 per diluted share, from $22.7 million, or $4.70 per share, for fiscal 2023.
The company also announced a quarterly cash dividend to shareholders of $1.00 per share of common stock, payable May 31, 2024 to shareholders of record as of May 13, 2024.
“We are pleased to report solid earnings for the quarter and fiscal year despite a semiconductor industry downturn,” said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.
Statements used in this press release that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as our reliance on several large customers for a significant percentage of revenue, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, risks and uncertainties related to future dividend payments, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024.
###
NVE CORPORATION | |||||||
| Quarter Ended March 31, | ||||||
| 2024 |
| 2023 | ||||
Revenue | |||||||
Product sales | $ | 7,034,840 |
|
| $ | 12,408,832 |
|
Contract research and development |
| 48,389 |
|
|
| 388,851 |
|
Total revenue |
| 7,083,229 |
|
|
| 12,797,683 |
|
Cost of sales |
| 1,737,977 |
|
|
| 2,529,311 |
|
Gross profit |
| 5,345,252 |
|
|
| 10,268,372 |
|
Expenses |
|
|
|
|
|
|
|
Research and development |
| 811,339 |
|
|
| 611,489 |
|
Selling, general, and administrative |
| 473,622 |
|
|
| 752,710 |
|
Total expenses |
| 1,284,961 |
|
|
| 1,364,199 |
|
Income from operations |
| 4,060,291 |
|
|
| 8,904,173 |
|
Interest income |
| 508,431 |
|
|
| 408,127 |
|
Income before taxes |
| 4,568,722 |
|
|
| 9,312,300 |
|
Provision for income taxes |
| 755,741 |
|
|
| 1,079,656 |
|
Net income | $ | 3,812,981 |
|
| $ | 8,232,644 |
|
Net income per share – basic | $ | 0.79 |
|
| $ | 1.70 |
|
Net income per share – diluted | $ | 0.79 |
|
| $ | 1.70 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
Basic |
| 4,833,610 |
|
|
| 4,830,826 |
|
Diluted |
| 4,839,556 |
|
|
| 4,836,365 |
|
| |||||||
| Year Ended March 31, | ||||||
2024 |
| 2023 | |||||
Revenue | |||||||
Product sales | $ | 29,218,063 |
|
| $ | 37,196,717 |
|
Contract research and development |
| 586,116 |
|
|
| 1,056,875 |
|
Total revenue |
| 29,804,179 |
|
|
| 38,253,592 |
|
Cost of sales |
| 6,772,533 |
|
|
| 8,062,311 |
|
Gross profit |
| 23,031,646 |
|
|
| 30,191,281 |
|
Expenses |
|
|
|
|
|
|
|
Research and development |
| 2,731,434 |
|
|
| 2,583,994 |
|
Selling, general, and administrative |
| 1,771,833 |
|
|
| 1,963,105 |
|
Provision for credit losses |
| 9,514 |
|
|
| - |
|
Total expenses |
| 4,512,781 |
|
|
| 4,547,099 |
|
Income from operations |
| 18,518,865 |
|
|
| 25,644,182 |
|
Interest income |
| 1,948,720 |
|
|
| 1,448,655 |
|
Income before taxes |
| 20,467,585 |
|
|
| 27,092,837 |
|
Provision for income taxes |
| 3,342,886 |
|
|
| 4,398,379 |
|
Net income | $ | 17,124,699 |
|
| $ | 22,694,458 |
|
Net income per share – basic | $ | 3.54 |
|
| $ | 4.70 |
|
Net income per share – diluted | $ | 3.54 |
|
| $ | 4.70 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
Basic |
| 4,833,146 |
|
|
| 4,830,826 |
|
Diluted |
| 4,839,705 |
|
|
| 4,832,096 |
|
NVE CORPORATION | |||||||
|
|
|
| ||||
| March 31, 2024 |
| March 31, 2023 | ||||
ASSETS | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 10,283,550 |
|
| $ | 1,669,896 |
|
Marketable securities, short-term (amortized cost of $12,283,630 as of March 31, 2024 and $15,696,135 as of March 31, 2023) |
| 11,917,779 |
|
|
| 15,513,095 |
|
Accounts receivable, net of allowance for credit losses of $15,000 |
| 3,144,833 |
|
|
| 6,523,344 |
|
Inventories |
| 7,158,585 |
|
|
| 6,417,010 |
|
Prepaid expenses and other assets |
| 689,349 |
|
|
| 663,459 |
|
Total current assets |
| 33,194,096 |
|
|
| 30,786,804 |
|
Fixed assets |
|
|
|
|
|
|
|
Machinery and equipment |
| 10,501,096 |
|
|
| 10,484,365 |
|
Leasehold improvements |
| 1,956,309 |
|
| 1,956,309 |
| |
|
| 12,457,405 |
|
|
| 12,440,674 |
|
Less accumulated depreciation and amortization |
| 11,403,383 |
|
| 11,095,236 |
| |
Net fixed assets |
| 1,054,022 |
|
|
| 1,345,438 |
|
Deferred tax assets |
| 1,453,704 |
|
| 572,038 |
| |
Marketable securities, long-term (amortized cost of $31,417,890 as of March 31, 2024, and $37,495,846 as of March 31, 2023) |
| 30,788,301 |
|
| 36,125,047 |
| |
Right-of-use asset – operating lease |
| 289,910 |
|
| 425,843 |
| |
Total assets | $ | 66,780,033 |
|
| $ | 69,255,170 |
|
| |||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Current liabilities | |||||||
Accounts payable | $ | 127,154 |
|
| $ | 281,712 |
|
Accrued payroll and other |
| 729,215 |
|
| 1,375,250 |
| |
Operating lease |
| 179,372 |
|
| 175,798 |
| |
Total current liabilities |
| 1,035,741 |
|
|
| 1,832,760 |
|
Operating lease |
| 175,775 |
|
| 342,908 |
| |
Total liabilities |
| 1,211,516 |
|
| 2,175,668 |
| |
|
|
|
|
|
|
|
|
Shareholders’ equity |
|
|
|
|
|
|
|
Common stock |
| 48,337 |
|
|
| 48,308 |
|
Additional paid-in capital |
| 19,554,812 |
|
|
| 19,295,442 |
|
Accumulated other comprehensive income |
| (777,637 | ) |
|
| (1,213,858 | ) |
Retained earnings |
| 46,743,005 |
|
| 48,949,610 |
| |
Total shareholders’ equity |
| 65,568,517 |
|
| 67,079,502 |
| |
Total liabilities and shareholders’ equity | $ | 66,780,033 |
|
| $ | 69,255,170 |
|
'?^?_ %+_ +^C_"C_ (45X=_Y_P#4O^_H M_P */KF#_P"?8?5\1_.>/_V_XB_Z&'4O^_QH_M_Q%_T,.I?]_C7L'_"BO#O_ M #_ZE_W]'^%'_"BO#O\ S_ZE_P!_1_A1]
XACAUW4I)&D4!/-)R,\UZ_P#\**\._P#/_J7_ ']'^%7M&^#N
M@Z+J\&HQ75[+)#]U97!7^51/%X1Q:C3U''#UTTW,[RQ61;& 2L6DV+N)[G%6
M* , =J*\D] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYKSOXR:5!KGQP\,Z5 D:[\-/ 7AI(VU?7KRV,GW%>< M].*ET;X5^!_$%LUQI6O7=U&G#
M^7.#L/H?2CZY@_\ GV'U?$?SGF7]O^(O^AAU+_O\:](^#-_K6JZKJ376J3W5
MO;E0RSN6.2.U/M_A;X)N[^YL;?6-0EGMAF8)*#MXSS74_#PQ;65Y#X<;T
M[C! ^7I]#/&F@Z3>^&O#^IZ0-"E:06LUV)/M-HDA)90%&UL$G!)
M[_@/3:* /+=-^&^L6>C^ [22YL#)X?NY)[HK(^'5G)&SY>3SWQ5O3O"?C+PS
MJ.MP^'KW1&T[5+V2]$UZLIG@=\;N%&'QCC)'OUKT>B@#R>+X5ZLGPUUOPQ)J
M5M+=W.J&^M;IBV'&Y"/-&W()VG.,X)ZFMN_\,>*9M4TWQ397.DVWB2*V:SO+
M
<@99[&=__E#O$V^]%V&2#%"LL\S^:U%]&D*
MAC/F2=_($I?L/Z_;JWD>9-0J^>^*!\S9TM 4,U7'*=IE\I'Z/IN0C]SLEWI+
MHJ